Get started
Author

Zhongcai Wu

Observed names: WU Zhongcai, Wu Zhong-cai, Wu, Zhongcai
Institution: Wuhan Puai Hospital
ORCID: 0000-0002-0110-9791
Observed ORCID: 0000-0002-0110-9791
OpenAlex ID: A5010204464
The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease
2021 · Han Zhu, Chujin Cao, et al. · Cell Metabolism · 291
PDF
Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
2017 · Xiaoxue Zhang, Dan Liu, et al. · Journal of Hematology & Oncology · 98
PDF
The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease
2021 · Han Zhu, Chujin Cao, et al. · Cell Metabolism · 62
PDF
The probiotic Lactobacillus casei Zhang-mediated correction of gut dysbiosis ameliorates peritoneal fibrosis by suppressing macrophage-related inflammation via the butyrate/PPAR-γ/NF-κB pathway
2023 · Zhongcai Wu, Xuezhi Zuo, et al. · Food & Function · 44
Immunoregulatory effects of Huaier (Trametes robiniophila Murr) and relevant clinical applications
2023 · Hongrong Long, Zhongcai Wu · Frontiers in Immunology · 33
PDF
Shrunken Pore Syndrome Is Associated with Renal Function Decline in Female Patients with Kidney Diseases
2022 · Zhongcai Wu, Le Wang, et al. · BioMed Research International · 8
PDF
Sex-specific associations between depression and cardiovascular–kidney–metabolic syndrome progression: a national cohort study
2026 · Qi Gao, Weirong Ren, et al. · European Journal of Preventive Cardiology · 7
Identification of Major Risk Factors and Non-linear Effects to the Development of Left Ventricular Hypertrophy in Chronic Kidney Disease by Constructing and Validation of Nomograms
2022 · Zhongcai Wu, Mengxia Shi, et al. · Frontiers in Medicine · 6
PDF
Additional file 6: Figure S4. of Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
2017 · Xiaoxue Zhang, Liu, Dan, et al. · Figshare
Additional file 7: of Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
2017 · Xiaoxue Zhang, Liu, Dan, et al. · Figshare
Additional file 3: Table S2. of Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
2017 · Zhang, Xiaoxue, Liu, Dan, et al. · Figshare
Additional file 1: Table S1. of Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
2017 · Zhang, Xiaoxue, Liu, Dan, et al. · Figshare
Works count: 20
Citation count: 549
H-index: 7
I10-index: 5
Year
Topic
Type